Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Fragmentation Kit

October 14, 2010 8:22 am | Drug Discovery & Development | Product Releases | Comments

These kits are designed for the generation and isolation of Fab and F(ab)2 fragments from immunoglobulin G (IgG). Utilizing G-Biosciences’ Immobilized Papain and Immobilized Pepsin, these enzymes cleave IgG near the hinge region to segregate Fab and F(ab)2 molecules.

TOPICS:

Novartis Signs Agreement With Synthetic Genomics

October 14, 2010 8:09 am | News | Comments

Novartis announced an agreement with Synthetic Genomics Vaccines Inc. to apply "synthetic genomics" technologies to accelerate the production of the influenza seed strains required for vaccine manufacturing.

TOPICS:

Roche Sales Down 7% for Quarter

October 14, 2010 8:04 am | News | Comments

Pharmaceuticals maker Roche Holding AG reported its third quarter sales dropped 7 percent on lower demand for its antiviral Tamiflu. Sales have dropped almost a billion dollars since a year ago.

TOPICS:
Advertisement

BMS, Otsuka Launch Drug Support Service

October 14, 2010 7:42 am | News | Comments

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced the launch of My SPRYCEL Support, a useful resource to assist adult patients with chronic myeloid leukemia who are taking SPRYCEL.

TOPICS:

Acceleron Annouces ACE-031 Study Results

October 14, 2010 7:39 am | News | Comments

Acceleron Pharma, Inc. announced preliminary results from a Phase 1b study to assess the safety, tolerability and pharmacodynamic activity of ACE-031 following multiple ascending doses in healthy postmenopausal volunteers.

TOPICS:

Researchers Answer Important Arsenite Question

October 14, 2010 7:34 am | News | Comments

Scientists have solved an important mystery about why an arsenic compound, called arsenite, can kill us, and yet function as an effective therapeutic agent against disease and infections.

TOPICS:

Simponi Arbitration Panel Unlikely to Rule Until 2011

October 14, 2010 7:29 am | by Linda A. Johnson | News | Comments

Drugmaker Merck & Co. says it doesn't expect arbitrators to rule until next year on its multi-billion-dollar dispute with Johnson & Johnson over rights to two pricey drugs for immune disorders.

TOPICS:

Scientists Link AD And apoE4

October 14, 2010 7:06 am | News | Comments

The lipid-transport protein apolipoprotein E4 is a major genetic risk factor for AD, and apoE4 carriers account for 65% of all Alzheimer's cases. Now, researchers from Gladstone Institutes have provided some insight into how exactly apoE4 might be involved.

TOPICS:
Advertisement

President Clears Way for Drug Take-Backs

October 14, 2010 6:53 am | News | Comments

States and private entities can now create prescription drug take-back programs to help people safely dispose of old or unwanted medicine.

TOPICS:

Increased Risk of Fracture with Bisphosphonates

October 14, 2010 6:52 am | by Matthew Perrone | News | Comments

Government health officials warned doctors and patients about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs.

TOPICS:

WHO Says A Billion Infected With Neglected Diseases

October 14, 2010 6:47 am | by Colleen Barry | News | Comments

The World Health Organization estimated that 1 billion of the world's poorest people suffer from neglected tropical diseases such as dengue, rabies and leprosy that remain concentrated in remote rural areas and urban slums despite being mostly eradicated elsewhere.

TOPICS:

FDA Considers Restricting Amgen Anemia Drugs

October 14, 2010 6:39 am | by Matthew Perrone | News | Comments

The Food and Drug Administration is considering new restrictions on widely used anemia drugs that appear to double the risk of stroke in patients with kidney disease.

TOPICS:

Color Snapshot Tracks Blood Flow

October 13, 2010 12:26 pm | by Eric Selvin Smith, Siemens Healthcare, Malvern, Pa. | Articles | Comments

Clinicians now are able to use, view, or assess 2D digital subtraction angiography (DSA) data without increasing X-ray dose or contrast medium. The syngo iFlow from Siemens Healthcare supports the creation of a static image displaying dynamic information, making flow visualization easier.

TOPICS:

Alzheimer’s Research Forges Ahead

October 13, 2010 11:21 am | by Catherine Shaffer, Contributing Writer | Articles | Comments

Alzheimer’s disease (AD) has been one of the most hotly pursued—and most elusive—therapeutic areas in biomedical research. Currently, there are no disease-modifying therapies available.

TOPICS:

Stem Cell Screening

October 13, 2010 8:49 am | Product Releases | Comments

Plasticell, the biotechnology company specialising in high throughput screening for stem cell differentiation, has launched its second generation CombiCult 10,000-plex screen capable of rapidly screening up to ten thousand cell culture media combinations.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading